Nimali Weerasooriya, MD
Obstetrics & Gynecology · Voorhees, NJNPI 1952896540
Payments from drug & device makers
Across 68 payments — averaging $19.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$303
- AbbVie$174
- Exeltis, USA Inc.$137
- Shield Therapeutics Inc$135
- Sumitomo Pharma America, Inc.$115
- Sage Therapeutics, LLC$86
- plus $382 from 13 others
What the payments were for
- Food & beverage$1,25294%
- Education$806%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 15 | $303 |
| AbbVie | 14 | $174 |
| Exeltis, USA Inc. | 6 | $137 |
| Shield Therapeutics Inc | 2 | $135 |
| Sumitomo Pharma America, Inc. | 7 | $115 |
| Sage Therapeutics, LLC | 5 | $86 |
| Pfizer | 4 | $67 |
| Coopersurgical, Inc. | 2 | $63 |
| Medicem Inc. | 1 | $33 |
| Organon | 2 | $33 |
| Exact Sciences | 1 | $27 |
| Bayer | 1 | $25 |
| Mayne Pharma Commercial LLC | 2 | $24 |
| Convatec Inc. | 1 | $24 |
| Hologic Sales And Service, LLC | 1 | $23 |
| Urovant Sciences Inc | 1 | $17 |
| Millicent US Inc | 1 | $16 |
| Medical Device Business Services, Inc. | 1 | $16 |
| Evofem Biosciences, Inc. | 1 | $13 |
How this compares
$1,331 in reported general payments places this provider in the 65th percentile of 1,242 obstetrics & gynecology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Nystatin-TriamcinoloneNystatin/Triamcinolone Acet | 13 | $237 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Voorhees
- Geoffrey BowersVoorhees$228K
- Paula JasionowskiVoorhees$193K
- Jeffrey LevineVoorhees$15K
- Richard DittrichVoorhees$9K
- Donna D EliaVoorhees$9K
- Jennifer AshtonEnglewood$1.5M
- Gregory HirschMorristown$1.3M
- Steven SussmanLawrenceville$623K
- Neha DeshpandePlainsboro$206K
- Justin ChuraSwedesboro$193K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.